Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Phenol recalled?

Not under an active recall. Phenol was recalled 28 times in the past — all now closed. Most recent: Aug 9, 2023.

Most common reason: Sterility / contamination (19 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Phenol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Phenol recalls in 2026

2 initiated in 2026, 28 in total — newest first
Class II · Moderate risk

Unguentine Ointment

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Completed cGMP deviation Ecometics, Inc. D-1099-2023
Class II · Moderate risk

Phenol 10%

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Terminated Sterility / contamination Pharmacy Innovations D-0229-2023
Class II · Moderate risk

Phenol

CGMP Deviations

Terminated cGMP deviation Edge Pharma, LLC NDC 05446-1211-03 D-0443-2022
Class II · Moderate risk

Phenol

Lack of Assurance of Sterility

Terminated Sterility / contamination Edge Pharma, LLC NDC 05446-1476-05 D-0413-2022
Class I · High risk

Prolotherapy with Phenol

Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Terminated Sterility / contamination Hartley Medical Center Pharmacy, Incorporated D-1830-2015
Class I · High risk

Prolotherapy with Phenol

Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Terminated Sterility / contamination Hartley Medical Center Pharmacy, Incorporated D-1829-2015
Class II · Moderate risk

Phenol 6% Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1398-2015
Class II · Moderate risk

Phenolphthalein active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-839-2015
Class II · Moderate risk

Phenol 10% injectable packaged in an amber glass injectable vial

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Terminated Sterility / contamination Martin Avenue Pharmacy, Inc. D-0117-2015